Healing · 50mg × 10 vials
the body uses GHK-Cu as a "repair this tissue" signal, copper goes in as a cofactor, fibroblasts wake up, collagen and elastin go up, inflammation goes down, blood supply improves.
GHK-Cu is a naturally occurring tripeptide (glycyl-L-histidyl-L-lysine) bound to a copper(II) ion. It circulates in human plasma at high levels in youth (~200 ng/ml at age 20) and drops sharply with age (~80 ng/ml by 60), which is the framing Pickart used in his foundational work to position GHK-Cu as a "youth signal" the body loses over time. Mechanistically it's the most gene-active peptide in the entire space: a 2010 Broad Institute Connectivity Map analysis showed GHK modulates expression of over 4,000 human genes, roughly a third of the genome, pushing the transcriptome of aged or damaged cells back toward a younger profile. The dominant effects are upregulation of collagen I, III, and IV synthesis, fibronectin, decorin, and glycosaminoglycans in dermal fibroblasts; modulation of metalloproteinases (MMPs) and their inhibitors (TIMPs) so collagen turnover is balanced rather than runaway breakdown; angiogenesis via VEGF induction; and TGF-beta superfamily activation that drives the wound-repair cascade. The copper ion is the load-carrying piece: GHK is the chaperone that delivers copper into cells where it serves as a cofactor for lysyl oxidase (collagen/elastin crosslinking) and superoxide dismutase (antioxidant defense). Plasma half-life is short (25-60 minutes systemically per pharmacokinetic studies, copper transport rapid) but tissue-bound effects on MMP activity and collagen turnover persist 24-72 hours and the regenerative cascade plays out over weeks. In plain language: the body uses GHK-Cu as a "repair this tissue" signal, copper goes in as a cofactor, fibroblasts wake up, collagen and elastin go up, inflammation goes down, blood supply improves.
Typical dose ranges by experience level - educational reference. Message us and we tailor it to you.
For first-timers Jordan defaults to a 50 mg vial (50 days of research at 1 mg/day, exactly one full Pickart cycle). Skin and hair changes are slow, real visible difference shows up around weeks 4-8, not days. If only goal is surface aging/wrinkles, topical alone is often enough. If goal is hair, wound healing, scar reduction, or systemic anti-aging, inject.
This is the band where most PP customers run GHK-Cu, especially when paired with reta for anti-aging or with BPC/TB for systemic healing. 50 mg vial at 2 mg/day = 25 days per vial, so a 50 mg kit (10 vials) is ~8 months of research. 100 mg kit doubles that runway for not much more money, which is why Jordan defaults customers toward 100 mg when budget allows.
Top-end protocols pair injectable GHK-Cu with microneedling-assisted topical on the same target area. Diabetic ulcer clinical work used 0.3% topical gel as the sweet spot for wound closure speed (3x faster than placebo). Advanced users often run GHK-Cu inside the GLOW or KLOW blends rather than solo to get BPC-157 and TB-500 systemic healing layered in.
Straight talk - what people actually report, and what the studies measured.
Peer-reviewed studies and clinical guidelines - tap any to read the source.
Connectivity Map analysis, GHK modulates 4,000+ human genes
Read study ↗PubMedGHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration (PMC4508379)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508379/) - comprehensive review of skin/wound pathways
Read study ↗PubMedRegenerative and Protective Actions of GHK-Cu in Light of New Gene Data (PMC6073405)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073405/) - Pickart 2018 update on gene-level mechanisms
Read study ↗PubMedThe Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging, Pickart 2012oxidative stress, cognitive health framing
Read study ↗PubMedSkin Regenerative and Anti-Cancer Actions of Copper Peptides, MDPI 2018anti-cancer signal review, addresses tumor-environment concerns
Read study ↗PubMedEnhanced healing of diabetic ulcers with topical GHK-Cudiabetic wound trial, 3x faster closure vs placebo at 0.3% topical
Read study ↗Aggregated sentiment from public forums & socials - real-world reports, not individual endorsements.
Injection site irritation: most-reported sensation, mild stinging or redness, rotates out with site rotation
Cloudy reconstitution: not a side effect but a reconstitution quirk customers flag; the blue solution can appear cloudy if mixed too fast or stored cold, resolves on gentle swirling and warming to room temp
Temporary headache/light dizziness after injection: rare, low single-digit anecdotal reports, usually resolves in hours
Skin tingling at topical application site: common at 0.5%+ topical, usually transient
Staining: the copper-blue color stains fabric if a vial leaks or topical drips; not a side effect but a customer-experience flag
Hair shedding "telogen rush" first 2-4 weeks of hair protocols: documented with minoxidil and reported less commonly with GHK-Cu; some forum users describe a brief shed before regrowth phase
Route: SubQ injection, topical (compounded cream/serum), or microneedling-assisted
Injection site: Abdomen or outer thigh, rotate sites. For targeted skin/hair use, some users inject near (not into) the target area; for systemic/wound use, standard SubQ.
Storage: Refrigerated, 28-30 days. Solution is light blue from the copper ion, this is normal and not a contamination signal. Cloudiness on reconstitution can occur from rapid mixing or temperature shock and resolves on gentle swirling; if it persists, the vial is suspect.
Notes: For topical use, GHK-Cu raw powder (1g size) is dissolved in distilled water or a hyaluronic acid base at 0.05-1% concentration; community DIY serums commonly run 0.1-0.5% nightly. Microneedling-assisted application (0.25-0.5 mm dermapen) increases dermal absorption ~20-fold versus topical alone per published in vitro data. Light-sensitive, store in original vial. The blue color WILL stain fabric if spilled.